GlobalData on MSN2d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
American Association of Individual Investors2d
Why Zentalis Pharmaceuticals, Inc.’s (ZNTL) Stock Is Down 21.25%
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...
pharmaphorum2d
OS data set up wider Jemperli use in endometrial cancer
GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in the RUBY trial.
pharmaphorum3d
NICE backs frontline use of Jemperli in endometrial cancer
GSK’s PD-1 inhibitor Jemperli has been cleared for use by the NHS as a first-line treatment for a specific type of endometrial cancer, making it an option for around 580 women across England ...
unilad3d
Scientists creating 'cancer vaccine' that could potentially stop the disease '20 years early'
Scientists at a university in the UK are in the midst of creating a breakthrough vaccine that could stop cancer in its tracks ...
Advanced Cervical Cancer FDA Approvals, Clinical Trials Assessment, Pipeline Insights and Companies | DelveInsight
DelveInsight’s Advanced Cervical Cancer pipeline report depicts a robust space with 70+ active players working to develop 75+ ...
Pharmaceutical Technology3d
GSK and University of Oxford partner for cancer vaccine research
The EMA’s acceptance of the prefilled syringe follows the European Commission’s (EC) approval of GSK’s Jemperli, combined with chemotherapy for the treatment of advanced or recurrent endometrial ...